CHWY vs IDXX vs GIS Stock Comparison

Chewy, Idexx Laboratories and General Mills Prices as of Nov 13, 2026 Peers: Industry group
CHWY Chewy, Inc.
$22.51 +8.0% 1M -32.8% 1Y
Market cap
$8.79B
P/E
32.1x
Revenue (TTM)
$13.07B
Div. yield
–
Packaged Foods Consumer Staples
2 wins
GIS General Mills Inc
$34.33 +6.8% 1M -27.5% 1Y
Market cap
$18.98B
P/E
–
Revenue (TTM)
$18.30B
Div. yield
0.07%
Packaged Foods Consumer Staples
2 wins

Head to Head

11 decided of 12

Idexx Laboratories leads on 7 of the 12 questions below (Idexx Laboratories 7, Chewy 2, General Mills 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCHWYIDXXGISLeader
Larger companyMarket capitalisation $8.79B $55.34B $18.98B IDXX
Cheaper on earningsLower P/E, profitable companies only 32.1x 46.8x -21.2x CHWY
Cheaper on forward earningsLower price / next fiscal year consensus EPS 30.0x 44.6x 10.8x GIS
Faster revenue growthRevenue growth, trailing twelve months +5.9% +11.9% -4.5% IDXX
More profitableNet margin, trailing twelve months 2.1% 25.4% -4.9% IDXX
Better return on capitalReturn on invested capital — 45.4% -1.0% IDXX
Less leveragedLower net debt / EBITDA 0.0x 0.4x 37.7x CHWY
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.07% –
Better 1-year returnPrice return, last 12 months -32.8% +0.4% -27.5% IDXX
Better 5-year returnAnnualised price return, 5 years -21.8%/yr +2.3%/yr -11.5%/yr IDXX
Less volatileAnnualised volatility, 1 year 47.7% 36.2% 31.0% GIS
Higher overall scoreMean of the five percentile scores vs peers 70/100 76/100 34/100 IDXX

Percentile Scorecard

CHWYIDXXGIS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCHWYIDXXGIS
Valuation 56 #21 of 46 74 #175 of 660 42 #27 of 46
Growth 90 #5 of 42 70 #184 of 619 7 #39 of 42
Profitability 60 #17 of 41 98 #12 of 595 45 #23 of 41
Financial Health 57 #21 of 48 46 #371 of 683 15 #41 of 48
Shareholder Returns 85 #6 of 34 94 #30 of 459 61 #14 of 34
Overall 70 76 34
  • CHWY ranked among 48 companies in Branded Foods
  • IDXX ranked among 695 companies in Pharmaceuticals and Biotechnology
  • GIS ranked among 48 companies in Branded Foods

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCHWYIDXXGISSPY
1 month +8.0%+33.1%+6.8% -2.0%
3 months +0.4%+27.8%-12.4% -2.8%
6 months +5.8%+33.2%+4.1% +2.0%
Year to date -31.9%+4.1%-26.2% +10.6%
1 year -32.8%+0.4%-27.5% +12.2%
3 years +11.6%+55.0%-47.3% +68.1%
3 years, per year +3.7%+15.7%-19.2% +18.9%
5 years -70.7%+12.1%-45.7% +61.4%
5 years, per year -21.8%+2.3%-11.5% +10.1%
10 years —+545.1%-43.8% +248.5%
10 years, per year —+20.5%-5.6% +13.3%

Risk

MeasureCHWYIDXXGISSPY
Volatility, 1Y 47.7%36.2%31.0% 13.6%
Downside volatility, 1Y 48.1%32.6%31.3% 13.9%
Beta vs S&P 500, 1Y 0.820.84-0.37 1.00
Return / volatility, 1Y -0.690.01-0.89 0.90
Max drawdown, 5Y -80.3%-50.9%-65.1% -25.4%
From 52-week high -36.4%-8.1%-30.0% -3.2%
52-week high $35.37$766.68$49.01 $779.14
52-week low $17.51$504.70$31.66 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCHWYIDXXGIS
P/E now vs peer median 33.4xmedian 18.9x 47.0xmedian 17.0x -20.6xmedian 18.9x
P/S now vs peer median 0.7xmedian 0.9x 11.9xmedian 8.4x 1.0xmedian 0.9x
EV/EBITDA now vs peer median 19.1xmedian 12.8x 33.7xmedian 14.6x 90.1xmedian 12.8x
P/FCF now vs peer median 15.9xmedian 13.7x 42.6xmedian 19.0x 11.9xmedian 13.7x
P/B now vs peer median 24.4xmedian 1.6x 29.7xmedian 2.0x 2.5xmedian 1.6x
PEG now vs peer median 0.44median 0.70 3.10median 0.43 0.61median 0.70

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCHWYIDXXGIS
Revenue $13.07B $4.66B $18.30B
Gross profit $3.91B $2.92B $6.15B
Operating income $328.20M $1.51B -$206.40M
Net income $273.70M $1.18B -$893.70M
Free cash flow $568.10M $1.30B $1.55B
R&D – $266.87M –
EPS (diluted) $0.67 $14.96 $-1.66
Cash & equivalents $611.00M $197.54M $433.10M
Total debt $591.70M $848.88M $13.62B
Shares (diluted) 410.10M 79.05M 537.90M
Enterprise value $6.08B $54.56B $16.63B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCHWYIDXXGIS
P/E 33.4x 47.0x -20.6x
P/FCF 15.9x 42.6x 11.9x
P/Operating cash flow 12.6x 39.1x 8.9x
P/S 0.7x 11.9x 1.0x
P/B 24.4x 29.7x 2.5x
P/Tangible book 40.9x 31.7x 24.4x
EV/EBITDA 19.1x 33.7x 90.1x
EV/EBIT 27.5x 37.3x -152.8x
EV/Revenue 0.7x 12.0x 1.7x
EV/FCF 15.9x 43.1x 20.4x
EV/Operating cash flow 12.6x 39.6x 15.3x
PEG (3Y EPS CAGR) 0.44 3.10 0.61

Growth

14 metrics
MetricCHWYIDXXGIS
Revenue growth (1Y) 5.9% 11.9% -4.5%
Revenue CAGR (3Y) 6.4% 9.1% -3.4%
Gross profit growth (1Y) 7.6% 13.7% -6.5%
Gross profit CAGR (3Y) 8.5% 10.8% -3.6%
Operating income growth (1Y) 102.0% 15.3% -104.9%
Operating income CAGR (3Y) 139.1% 11.8% -27.2%
Net income growth (1Y) 81.1% 15.1% -130.6%
Net income CAGR (3Y) 73.8% 12.8% -33.2%
EPS growth (1Y) 89.2% 17.4% -130.9%
EPS CAGR (3Y) 76.8% 15.1% -33.9%
Operating cash flow growth (1Y) 17.3% 30.4% -25.7%
Operating cash flow CAGR (3Y) 10.9% 19.6% -4.9%
Free cash flow growth (1Y) 22.7% 35.3% -28.2%
Free cash flow CAGR (3Y) 18.6% 24.2% -6.8%

Profitability

14 metrics
MetricCHWYIDXXGIS
Gross margin 29.9% 62.7% 33.6%
EBITDA margin 3.6% 35.7% 1.9%
Operating margin 2.5% 32.3% -1.1%
Pretax margin 2.7% 31.7% -3.8%
Net margin 2.1% 25.4% -4.9%
FCF margin 4.3% 28.0% 8.5%
Operating cash flow margin 5.5% 30.4% 11.3%
Return on equity 69.0% 67.9% -12.0%
Return on assets 7.8% 33.1% -3.0%
Return on invested capital – 45.4% -1.0%
Return on capital employed 24.9% 65.2% -0.9%
Asset turnover 3.7x 1.3x 0.6x
Cash conversion (OCF / net income) 2.6x 1.2x -2.3x
Stock comp / revenue 2.3% 1.4% 0.5%

Financial Health

11 metrics
MetricCHWYIDXXGIS
Debt / assets 15.8% 22.9% 45.0%
Debt / equity 1.6x 0.5x 1.8x
Net debt / EBITDA 0.0x 0.4x 37.7x
Debt / FCF 1.0x 0.7x 8.8x
Liabilities / assets 90.1% 49.6% 75.3%
Equity / assets 9.9% 50.4% 24.7%
Interest coverage – 43.5x -0.4x
Current ratio 0.8x 1.2x 0.7x
Quick ratio 0.4x 0.7x 0.3x
Cash ratio 0.3x 0.2x 0.1x
Altman Z-score 4.83 23.56 1.94

Shareholder Returns

7 metrics
MetricCHWYIDXXGIS
Dividend yield – – 7.1%
Net buyback yield 5.6% 1.7% –
Shareholder yield 5.6% 1.7% 7.1%
Payout ratio (earnings) – – -147.1%
Payout ratio (FCF) – – 85.0%
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCHWYIDXXGIS
Forward P/E 30.0xFY2026 44.6xFY2026 10.8xFY2026
EPS, next fiscal year $0.75FY2026 $15.78FY2026 $3.19FY2026
EPS growth, next FY +44.2%FY2026 +20.6%FY2026 -10.1%FY2026
EPS growth, the year after +49.3% +12.3% -5.0%
Revenue, next fiscal year $12.87BFY2026 $5.03BFY2026 $18.94BFY2026
Revenue growth, next FY +2.1%FY2026 +17.0%FY2026 +2.8%FY2026
Revenue growth, the year after +5.5% +0.4% -11.1%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCHWYIDXXGIS
Held by institutions 100.0% 93.6% 87.2%
Institutions holding 513 1,292 1,336
Change in shares held, QoQ -0.4% +4.1% +3.7%
Institutions buying 278 590 728
Institutions selling 156 496 428
Buyers to sellers 1.78 1.19 1.70

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CHWYIDXXGIS
CHWY 1.00 0.33 0.20
IDXX 0.33 1.00 0.22
GIS 0.20 0.22 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CHWY, IDXX and GIS?

Idexx Laboratories (IDXX) is the largest by market capitalisation: Chewy (CHWY) $8.79B, Idexx Laboratories (IDXX) $55.34B, General Mills (GIS) $18.98B.

Which stock is cheaper, CHWY, IDXX and GIS?

Chewy (CHWY) trades on the lowest price-to-earnings ratio (Chewy (CHWY) 32.1x, Idexx Laboratories (IDXX) 46.8x, General Mills (GIS) -21.2x). On next year's consensus earnings, General Mills (GIS) is cheapest (Chewy (CHWY) 30.0x, Idexx Laboratories (IDXX) 44.6x, General Mills (GIS) 10.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Idexx Laboratories (IDXX) grew revenue fastest over the trailing twelve months: Chewy (CHWY) +5.9%, Idexx Laboratories (IDXX) +11.9%, General Mills (GIS) -4.5%.

Which company is more profitable?

Idexx Laboratories (IDXX) has the highest net margin (Chewy (CHWY) 2.1%, Idexx Laboratories (IDXX) 25.4%, General Mills (GIS) -4.9%). On return on invested capital, Idexx Laboratories (IDXX) leads (Idexx Laboratories (IDXX) 45.4%, General Mills (GIS) -1.0%).

Which stock has performed better?

Over the past year Idexx Laboratories (IDXX) returned the most: Chewy (CHWY) -32.8%, Idexx Laboratories (IDXX) +0.4%, General Mills (GIS) -27.5%. Over five years, Idexx Laboratories (IDXX) compounded fastest (Chewy (CHWY) -21.8%/yr, Idexx Laboratories (IDXX) +2.3%/yr, General Mills (GIS) -11.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Chewy (CHWY) 0.00%, Idexx Laboratories (IDXX) 0.00%, General Mills (GIS) 0.07%. Chewy (CHWY) and Idexx Laboratories (IDXX) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, General Mills (GIS) has been the steadiest (Chewy (CHWY) 47.7%, Idexx Laboratories (IDXX) 36.2%, General Mills (GIS) 31.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CHWY, IDXX and GIS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Idexx Laboratories (IDXX) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.